Activation of calcium and phospholipid-dependent protein kinase by epidermal growth factor (EGF) in A431 cells: attenuation by 12-0-tetradecanoylphorbol-13-acetate (TPA).
D002294:Carcinoma, Squamous Cell / Q000201:enzymology*; D002460:Cell Line; D004075:Diglycerides / Q000494:pharmacology; D004336:Drug Antagonism; D004815:Epidermal Growth Factor / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D010704:Phorbols / Q000494:pharmacology*; D010743:Phospholipids / Q000494:pharmacology*; D011493:Protein Kinase C; D011494:Protein Kinases / Q000378:metabolism*; D013329:Structure-Activity Relationship; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D004075:Diglycerides; D010704:Phorbols; D010743:Phospholipids; D004815:Epidermal Growth Factor; D011494:Protein Kinases; D011493:Protein Kinase C; D013755:Tetradecanoylphorbol Acetate; C013965:diolein